Kedinger Valérie, Rio Marie-Christine
Departement de Pathologie Moléculaire, Institut de Génétique et de Biologie Moléculaire, CNRS UPR 6520/INSERM Unité 596/Université Louis Pasteur, Illkirch, France.
Adv Exp Med Biol. 2007;597:60-71. doi: 10.1007/978-0-387-70630-6_5.
The fourth member of the TRAF protein family (TRAF4) presents several characteristics that distinguish it from the other members of the family. These characteristics concern the primary sequence of the protein, a strong evolutionary conservation, and a tightly regulated physiological expression during development. The subcellular localization of TRAF4 is controversial as it has been detected at the cell membrane, in the cytoplasm and in the nucleus. Using mouse and fly models, it has been established that TRAF4 is a key molecule in diverse ontogenic processes, particularly in the nervous system. However, the molecular mechanisms of action of TRAF4 remain evasive as it was found to interact with diverse types of proteins, leading either to pro-apoptotic or anti-apoptotic functions. Finally, few studies implicated TRAF4 in human diseases.
肿瘤坏死因子受体相关因子蛋白家族的第四个成员(TRAF4)具有一些使其有别于该家族其他成员的特征。这些特征涉及该蛋白的一级序列、高度的进化保守性以及在发育过程中受到严格调控的生理表达。TRAF4的亚细胞定位存在争议,因为在细胞膜、细胞质和细胞核中均检测到了它。利用小鼠和果蝇模型已证实,TRAF4是多种个体发育过程中的关键分子,尤其是在神经系统中。然而,TRAF4的分子作用机制仍不明确,因为发现它能与多种类型的蛋白质相互作用,从而导致促凋亡或抗凋亡功能。最后,仅有少数研究表明TRAF4与人类疾病有关。